What is China Infrastructure Construction Corp. (CHNC)?

China Infrastructure Construction Corp. (CHNC) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of CHNC?

The current price of CHNC is $0.00. Prices are updated in real time on Stocks360.

What is CHNC's price-to-earnings (PE) ratio?

CHNC's trailing twelve-month PE ratio is 0.03, based on current price and earnings per share data available on Stocks360.

What is CHNC's market capitalization?

CHNC's market capitalization is $5,042,350.00, placing it in the small-cap tier.

China Infrastructure Construction Corp. (CHNC)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$5.04M

PE (TTM)

0.03

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.22

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

4.23M

China Infrastructure Construction Corp. (CHNC) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $5.04M. Trailing PE 0.03. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About China Infrastructure Construction Corp.

China Infrastructure Construction Corp. (CHNC), founded in Houston, Texas, in 2003, is primarily an educational provider specializing in medical cannabis. The company delivers its cannabis-focused curricula throughout the United States and Latin America, also offering worldwide access via online platforms. Beyond its educational endeavors, CHNC furnishes a range of therapeutic services. These include the execution of clinical trials and the operation of a dedicated fertility and sleep center situated in Houston, Texas. This center specifically addresses sleep-related conditions, particularly those that result in infertility. Additionally, through its division, Pharmacology University, CHNC provides a comprehensive array of services related to medical cannabis, including instruction, advisory support, digital content creation, promotional activities, and licensing for franchise operations.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	0.03×
P/S (TTM)	40.79×
P/B	-23.45×
P/FCF (TTM)	-51.79×
EV / EBITDA	-10.56×
EV / Sales	41.69×
Earnings Yield	-4.87%
Free Cash Flow Yield	-1.93%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.15M
Revenue (TTM)	$123.63K
Net Income (TTM)	-$245.60K
Free Cash Flow (TTM)	-$95.02K
Net Debt	$111.63K
Working Capital	-$1.22M
Gross Margin	78.78%
Operating Margin	-291.41%
Net Margin	-229.04%
Return on Equity	122.64%
Return on Invested Capital	32.58%